Streetbeat News

Earnings

GRTS

Over the past three months, four analysts have shared their evaluations of Gritstone Bio (NASDAQ:GRTS), revealing a mix of bullish and somewhat bullish sentiments. The average 12-month price target has decreased by 22.73% to $4.25. Analysts have adjusted their ratings and price targets, reflecting evolving market conditions and company performance. Gritstone Bio faces financial challenges, including a significant revenue decline, negative net margin, and high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

June 14, 2024 | 3:01 pm

AAPL

HPE

NTAP

PSTG

SMCI

The article provides a comprehensive comparison of Super Micro Computer (NASDAQ:SMCI) with its competitors in the Technology Hardware, Storage & Peripherals industry. Key financial metrics such as P/E, P/B, P/S, ROE, EBITDA, gross profit, and revenue growth are analyzed. Super Micro Computer shows strong financial performance and growth potential, with notable undervaluation in P/E and P/B ratios, high ROE, and exceptional revenue growth.

Portfolio Pulse from Benzinga Insights

June 14, 2024 | 3:00 pm

AMD

INTC

NVDA

QCOM

TSM

The article provides a comprehensive analysis of Taiwan Semiconductor Manufacturing Co. (NYSE: TSM) compared to its industry peers in the Semiconductors & Semiconductor Equipment sector. Key financial metrics such as P/E, P/B, P/S, ROE, EBITDA, gross profit, and revenue growth are evaluated, highlighting TSM's strong financial performance and growth prospects.

Portfolio Pulse from Benzinga Insights

June 14, 2024 | 3:00 pm

CARR

Over the past three months, 9 analysts have shared their evaluations of Carrier Global (NYSE:CARR), revealing a range of outlooks from bullish to bearish. The average 12-month price target has increased to $69.78, with a high estimate of $81.00 and a low estimate of $63.00. Recent analyst actions include several rating raises and price target adjustments, reflecting a generally positive sentiment. Carrier Global has shown a positive revenue trend but faces challenges in profitability, return on equity, return on assets, and debt management.

Portfolio Pulse from Benzinga Insights

June 14, 2024 | 3:00 pm

LLY

The article provides a comprehensive analysis of Eli Lilly and Co (NYSE:LLY) in comparison to its competitors in the Pharmaceuticals industry. It highlights that Eli Lilly has high valuation metrics (PE, PB, PS ratios) compared to industry norms, indicating potential overvaluation. However, the company shows strong profitability and growth prospects with a high ROE and significant revenue growth. Concerns are raised about its operational efficiency due to lower EBITDA and gross profit, and its higher debt-to-equity ratio suggests higher financial risk.

Portfolio Pulse from Benzinga Insights

June 14, 2024 | 3:00 pm

PDCO

Patterson Companies, Inc. (NASDAQ:PDCO) is set to release its fiscal 2024 Q4 financial results on Tuesday. Analysts expect a slight decline in earnings per share and revenue compared to the previous year. The company recently approved a $500 million stock buyback and declared a quarterly dividend. Analysts have mixed ratings on the stock, with recent downgrades and price target adjustments.

Portfolio Pulse from Avi Kapoor

June 14, 2024 | 2:46 pm

AAPL

GOOGL

META

MSFT

NVDA

QQQ

SPY

TSLA

The Market Clubhouse Morning Memo for June 14th, 2024, provides a detailed analysis of key price levels for SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA. The memo highlights potential bullish and bearish targets for each asset, emphasizing the importance of monitoring these levels for potential breakouts or reversals. Additionally, the memo notes the significance of the Import Price Index and the University of Michigan Sentiment report, which could influence market sentiment and volatility.

Portfolio Pulse from RIPS

June 14, 2024 | 2:43 pm

APIE

BCS

DFIV

Barclays PLC (NYSE:BCS) shares are trading lower on Friday following a directive from the Prudential Regulation Authority (PRA) to review its leveraged finance exposure. This move is part of a broader examination of U.K. banks' risk management in private equity investments. Barclays will conduct the review through a section 166 report. Despite reporting strong first-quarter FY24 net income, BCS stock is down 3.3% at $10.25. Investors can also gain exposure to Barclays via the Dimensional International Value ETF (NYSE:DFIV) and ActivePassive International Equity ETF (NYSE:APIE).

Portfolio Pulse from Shivani Kumaresan

June 14, 2024 | 2:40 pm

ADBE

ARM

HAS

IRON

OCUL

TPC

URGN

VFS

U.S. stocks were mostly lower on Friday, with the Dow Jones index falling around 300 points. However, several stocks saw significant gains. Hasbro, Inc. (NASDAQ:HAS) rose 5.5% after an upgrade from B of A Securities. Disc Medicine, Inc. (NASDAQ:IRON) gained 15.6% following a $178 million underwritten offering. UroGen Pharma Ltd. (NASDAQ:URGN) rose 15.4% due to positive Phase 3 trial results. Adobe Inc. (NASDAQ:ADBE) surged 14.3% on strong earnings. Other notable gainers include Ocular Therapeutix, Inc. (NASDAQ:OCUL), VinFast Auto Ltd. (NASDAQ:VFS), Tutor Perini Corporation (NYSE:TPC), and Arm Holdings plc (NASDAQ:ARM).

Portfolio Pulse from Avi Kapoor

June 14, 2024 | 2:29 pm

HPE

Recent analysis of Hewlett Packard's (NYSE:HPE) options activity reveals 14 unusual trades, with an equal split between bullish and bearish sentiments. The trades include 3 puts valued at $227,726 and 11 calls valued at $497,182. Analysts have mixed ratings on HPE, with price targets ranging from $17 to $26. The stock is currently trading at $21.44, down by 1.47%, with an RSI indicating it may be overbought.

Portfolio Pulse from Benzinga Insights

June 14, 2024 | 2:16 pm